We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+10.75%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$746M
AUM Growth
+$15.5M
(+2.1%)
Cap. Flow
-$23.2M
Cap. Flow
% of AUM
-3.12%
Top 10 Holdings %
Top 10 Hldgs %
84.69%
Holding
50
New
8
Increased
8
Reduced
3
Closed
21
Top Buys
| 1 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
+$28.5M |
| 2 |
MacroGenics
MGNX
|
+$21.3M |
| 3 |
IMDZ
Immune Design Corp.
IMDZ
|
+$19.4M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
+$18.6M |
| 5 |
APLS
Apellis Pharmaceuticals
APLS
|
+$16.8M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
+$40M |
| 2 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$21.3M |
| 3 |
Forte Biosciences
FBRX
|
+$18.7M |
| 4 |
CytomX Therapeutics
CTMX
|
+$15.1M |
| 5 |
Indaptus Therapeutics
INDP
|
+$13.4M |
Sector Composition
| 1 | Healthcare | 91.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Assembly Biosciences
ASMB
$531M
| $133M | 17.86% |
245,264
| – | – |
|
|
KYNB
2
Kyntra Bio
KYNB
$29.8M
| $97.1M | 13.02% |
81,909
+12,482
| +18% | +$15.7M |
|
3
Ironwood Pharmaceuticals
IRWD
$665M
| $88.2M | 11.83% |
7,027,386
+508,644
| +8% | +$6.64M |
|
4
Ascendis Pharma A/S
ASND
$17.6B
| $84.4M | 11.32% |
2,107,600
| – | – |
|
5
Kura Oncology
KURA
$1B
| $57.6M | 7.73% |
3,766,852
| – | – |
|
|
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $43.7M | 5.86% |
4,836,547
+3,878,555
| +405% | +$28.5M |
|
|
ARRY
7
DELISTED
Array Biopharma Inc
ARRY
| $36.9M | 4.95% |
2,882,712
+1,632,712
| +131% | +$18.6M |
|
8
Wave Life Sciences
WVE
$1.14B
| $32.9M | 4.41% |
936,163
+371,915
| +66% | +$10.8M |
|
|
MYOK
9
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $32.8M | 4.39% |
778,393
+88,407
| +13% | +$3.41M |
|
|
APLS
10
DELISTED
Apellis Pharmaceuticals
APLS
| $24.8M | 3.33% |
+1,144,558
| New | +$16.8M |
|
|
11
MacroGenics
MGNX
$271M
| $21.7M | 2.91% |
+1,140,794
| New | +$21.3M |
|
12
Rhythm Pharmaceuticals
RYTM
$7.52B
| $15.4M | 2.07% |
+530,161
| New | +$14M |
|
|
IMDZ
13
DELISTED
Immune Design Corp.
IMDZ
| $13.9M | 1.86% |
+3,562,600
| New | +$19.4M |
|
|
ATYR
14
aTyr Pharma
ATYR
$53.9M
| $13.7M | 1.84% |
279,855
-1,206
| -0.4% | -$74.2K |
|
|
LKFT
15
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
| $10.3M | 1.39% |
110,384
-130,392
| -54% | -$12.3M |
|
|
ONC
16
BeOne Medicines Ltd
ONC
$32.2B
| $8.18M | 1.1% |
83,667
+73,867
| +754% | +$6.76M |
|
17
Corvus Pharmaceuticals
CRVS
$1.26B
| $6.1M | 0.82% |
588,432
-320,093
| -35% | -$4.1M |
|
|
ACHN
18
DELISTED
Achillion Pharmaceuticals
ACHN
| $5.3M | 0.71% |
+1,840,725
| New | +$6.69M |
|
|
KIN
19
DELISTED
Kindred Biosciences, Inc.
KIN
| $5.15M | 0.69% |
544,880
| – | – |
|
|
CMTA
20
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $3.69M | 0.49% |
194,166
| – | – |
|
21
Madrigal Pharmaceuticals
MDGL
$12.8B
| $3.21M | 0.43% |
+35,000
| New | +$2M |
|
22
Denali Therapeutics
DNLI
$3.63B
| $3.13M | 0.42% |
+200,000
| New | +$3.59M |
|
23
Xencor
XNCR
$1.11B
| $2.48M | 0.33% |
112,976
+22,862
| +25% | +$496K |
|
|
MRTX
24
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.88M | 0.25% |
+103,240
| New | +$1.6M |
|
25
Aclaris Therapeutics
ACRS
$785M
| – | – |
-60,000
| Closed | -$1.55M |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM